EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.

Last updated 12 rujna 2024. Database contains 4821 unique substances/entries.

Filter the list

Prikaz 2.701 - 2.750 od 4.821 rezultata.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)
UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine ITC 826 CONCENTRATE	422-720-8	166242-53-1	Carc. 2; Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1
1-vinyl-2-pyrrolidone	201-800-4	88-12-0	Carc. 2; Acute Tox. 4; STOT RE 2; STOT SE 3; Eye Dam. 1
o-(p-isocyanatobenzyl)phenyl isocyanate; diphenylmethane-2,4'-diisocyanate	227-534-9	5873-54-1	Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
methylenediphenyl diisocyanate	247-714-0	26447-40-5	Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
4,4'-methylenediphenyl diisocyanate; diphenylmethane-4,4'-diisocyanate	202-966-0	101-68-8	Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
2,2'-methylenediphenyl diisocyanate; diphenylmethane-2,2'-diisocyanate	219-799-4	2536-05-2	Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
diuron (ISO); 3-(3,4-dichlorophenyl)-1,1-dimethylurea	206-354-4	330-54-1	Carc. 2; Acute Tox. 4; STOT RE 2
folpet (ISO);N-(trichloromethylthio)phthalimide	205-088-6	133-07-3	Carc. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
2,4,6-trichlorophenol	201-795-9	88-06-2	Carc. 2; Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2
diethylcarbamoyl chloride	201-798-5	88-10-8	Carc. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
3,5,5-trimethylcyclohex-2-enone; isophorone	201-126-0	78-59-1	Carc. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3
trisodium nitrilotriacetate	225-768-6	5064-31-3	Carc. 2; Acute Tox. 4; Eye Irrit. 2
salts of 4,4'-carbonimidoylbis[N, N-dimethylaniline] show/hide Decyl hydrogen sulphate, compound with 4,4'-carbonimidoylbis[N,N-dimethylaniline] (1:1) EC / List no: 281-828-1 \| CAS no: 84030-53-5 Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, mono(dodecylbenzenesulfonate) EC / List no: - \| CAS no: 82794-01-2 Benzenesulfonic acid, 4-dodecyl-, compd. with 4,4'-carbonimidoylbis(N,N-dimethylbenzenamine) (1:1) EC / List no: - \| CAS no: 63589-43-5 Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, monohydrochloride, 2-hydroxyethanesulfonate EC / List no: - \| CAS no: 86157-51-9 Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, monohydrochloride, (2-methoxyethoxy)acetate EC / List no: - \| CAS no: 82941-28-4 Methanaminium, N-(4-(amino(4-(dimethylamino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-methyl-, dodecyl(sulfophenoxy)benzenesulfonate (2:1) EC / List no: - \| CAS no: 63428-09-1 4,4'-carbonimidoylbis[N,N-dimethylanilinium] sulphate EC / List no: 282-562-9 \| CAS no: 84255-16-3 4,4'-carbonimidoylbis[N,N-dimethylaniline] acetate EC / List no: 225-801-4 \| CAS no: 5089-20-3 4,4'-carbonimidoylbis[N,N-dimethylaniline] nitrate EC / List no: 282-561-3 \| CAS no: 84255-15-2 4,4'-bis[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo][1,1'-biphenyl]-2,2'-disulphonic acid, compound with 4,4'-carbonimidoylbis[N,N-dimethylphenylamine] (1:2) EC / List no: 277-106-0 \| CAS no: 72939-51-6 4,4'-carbonimidoylbis(N,N-dimethylaniline) monohydrochloride EC / List no: 219-567-2 \| CAS no: 2465-27-2	-	-	Carc. 2; Acute Tox. 4; Eye Irrit. 2
4,4'-carbonimidoylbis[N, N-dimethylaniline]	207-762-5	492-80-8	Carc. 2; Acute Tox. 4; Eye Irrit. 2
C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no.202-027-5);C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride;[4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride; C.I. Basic Violet 3	208-953-6	548-62-9	Carc. 2; Acute Tox. 4; Eye Dam. 1
methyl iodide; iodomethane	200-819-5	74-88-4	Carc. 2; Acute Tox. 4; Acute Tox. 3; STOT SE 3; Skin Irrit. 2
tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one	618-075-9	87820-88-0	Carc. 2; Acute Tox. 4
naphthalene	202-049-5	91-20-3	Carc. 2; Acute Tox. 4
monuron (ISO); 3-(4-chlorophenyl)-1,1-dimethylurea	205-766-1	150-68-5	Carc. 2; Acute Tox. 4
di-allate (ISO); S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate	218-961-1	2303-16-4	Carc. 2; Acute Tox. 4
chlordimeform hydrochloride; N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride; N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride	243-269-1	19750-95-9	Carc. 2; Acute Tox. 4
chlordimeform (ISO); N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine	228-200-5	6164-98-3	Carc. 2; Acute Tox. 4
chlordane (ISO); 1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan	200-349-0	57-74-9	Carc. 2; Acute Tox. 4
carbaryl (ISO); 1-naphthyl methylcarbamate	200-555-0	63-25-2	Carc. 2; Acute Tox. 4
biphenyl-2-ylamine	201-990-9	90-41-5	Carc. 2; Acute Tox. 4
4,4'-methylenebis(2-ethylaniline); 4,4'-methylenebis(2-ethylbenzeneamine)	243-420-1	19900-65-3	Carc. 2; Acute Tox. 4
1,1,2-trichloroethane	201-166-9	79-00-5	Carc. 2; Acute Tox. 4
pirimicarb (ISO); 2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamate	245-430-1	23103-98-2	Carc. 2; Acute Tox. 3; Skin Sens. 1
propargite (ISO); 2-(4-tert-butylphenoxy)cyclohexyl prop-2-ynyl sulphite	219-006-1	2312-35-8	Carc. 2; Acute Tox. 3; Skin Irrit. 2; Eye Dam. 1
heptachlor epoxide; 2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane	213-831-0	1024-57-3	Carc. 2; Acute Tox. 3; STOT RE 2
heptachlor (ISO); 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene	200-962-3	76-44-8	Carc. 2; Acute Tox. 3; STOT RE 2
DDT (ISO); clofenotane (INN); dicophane;1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane; dichlorodiphenyltrichloroethane	200-024-3	50-29-3	Carc. 2; Acute Tox. 3; STOT RE 1
carbon tetrachloride; tetrachloromethane	200-262-8	56-23-5	Carc. 2; Acute Tox. 3; STOT RE 1
aldrin (ISO)	206-215-8	309-00-2	Carc. 2; Acute Tox. 3; STOT RE 1
toluidinium chloride	208-740-8	540-23-8	Carc. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
toluidine sulphate (1:1)	208-741-3	540-25-0	Carc. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
p-toluidine; 4-aminotoluene	203-403-1	106-49-0	Carc. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
captan (ISO);1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide	205-087-0	133-06-2	Carc. 2; Acute Tox. 3; Eye Dam. 1; Skin Sens. 1
α, α-dichlorotoluene; benzylidene chloride; benzal chloride	202-709-2	98-87-3	Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
camphechlor (ISO); toxaphene	232-283-3	8001-35-2	Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Skin Irrit. 2
azamethiphos (ISO); S-[(6-chloro-2-oxooxazolo [4,5-b]pyridin-3(2H)-yl) methyl] O,O-dimethyl thiophosphate	252-626-0	35575-96-3	Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT SE 1; Skin Sens. 1
furfuryl alcohol	202-626-1	98-00-0	Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3
2-furaldehyde	202-627-7	98-01-1	Carc. 2; Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
2,3,4-trichlorobut-1-ene	219-397-9	2431-50-7	Carc. 2; Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole	252-615-0	35554-44-0	Carc. 2; Acute Tox. 3; Acute Tox. 4; Eye Dam. 1
1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex	210-168-9	608-73-1	Carc. 2; Acute Tox. 3; Acute Tox. 4
bifenthrin (ISO); (2-methylbiphenyl-3-yl)methylrel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate	617-373-6	82657-04-3	Carc. 2; Acute Tox. 3; Acute Tox. 2; STOT RE 1; Skin Sens. 1B
N,N-dimethylaniline	204-493-5	121-69-7	Carc. 2; Acute Tox. 3
chlordecone (ISO); perchloropentacyclo[5,3,0,02,6,03,9,0 4,8]decan-5-one; decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one	205-601-3	143-50-0	Carc. 2; Acute Tox. 3
5-nitro-o-toluidine hydrochloride	256-960-8	51085-52-0	Carc. 2; Acute Tox. 3

Prikaz 2.701 - 2.750 od 4.821 rezultata.

Export search results to:

EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Contact Helpdesk

Last updated 12 rujna 2024. Database contains 4821 unique substances/entries.

Footer Nav Items